These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7447217)

  • 41. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The importance of vitamin K monitoring with warfarin (Coumadin) use in chronic kidney disease patients.
    Han H
    J Ren Nutr; 2015 Jan; 25(1):e7-8. PubMed ID: 25455420
    [No Abstract]   [Full Text] [Related]  

  • 43. Comment: Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets.
    Kalvass JC; Phinney SD; Vernon MC; Rosedale R; Westman EC
    Ann Pharmacother; 2005; 39(7-8):1371-2; author reply 1372. PubMed ID: 15928257
    [No Abstract]   [Full Text] [Related]  

  • 44. Resistance to oral vitamin K for reversal of overanticoagulation during Crohn's disease relapse.
    Fugate SE; Ramsey AM
    J Thromb Thrombolysis; 2004 Jun; 17(3):219-23. PubMed ID: 15353921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Consistent vitamin K helps warfarin do its job. Food can throw off warfarin's ability to prevent blood clots. Keeping your vitamin K intake relatively constant can help you avoid problems with this medication.
    Harv Heart Lett; 2004 Sep; 15(1):4. PubMed ID: 15381495
    [No Abstract]   [Full Text] [Related]  

  • 46. Dietary vitamin K guidance: an effective strategy for stable control of oral anticoagulation?
    Booth SL
    Nutr Rev; 2010 Mar; 68(3):178-81. PubMed ID: 20384848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A Systematic Review of the Acceptable Intake Level of Vitamin K among Warfarin Users].
    Sato Y; Murata M; Chiba T; Umegaki K
    Shokuhin Eiseigaku Zasshi; 2015; 56(4):157-65. PubMed ID: 26346860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated international normalized ratio from vitamin K supplement discontinuation.
    Miesner AR; Sullivan TS
    Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antidotal effect of vitamin K1 against warfarin-induced anticoagulation in horses.
    Byars TD; Greene CE; Kemp DT
    Am J Vet Res; 1986 Oct; 47(10):2309-12. PubMed ID: 3777660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitamin K intake and sensitivity to warfarin in patients consuming regular diets.
    Lubetsky A; Dekel-Stern E; Chetrit A; Lubin F; Halkin H
    Thromb Haemost; 1999 Mar; 81(3):396-9. PubMed ID: 10102468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin K requirement in Danish anticoagulant-resistant Norway rats (Rattus norvegicus).
    Markussen MD; Heiberg AC; Nielsen R; Leirs H
    Pest Manag Sci; 2003 Aug; 59(8):913-20. PubMed ID: 12916772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of preoperative vitamin K on the INR in bridging therapy.
    Bayewitz A; Scorziello B; Maala C; Giannattasio E; Billett HH
    Int J Hematol; 2015 Mar; 101(3):264-7. PubMed ID: 25637256
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticipating drug response. A commonly used anticoalgulant has many drug-drug interactions.
    Lilley LL; Guanci R
    Am J Nurs; 1998 Sep; 98(9):12. PubMed ID: 9739740
    [No Abstract]   [Full Text] [Related]  

  • 54. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.
    Crowther MA; Douketis JD; Schnurr T; Steidl L; Mera V; Ultori C; Venco A; Ageno W
    Ann Intern Med; 2002 Aug; 137(4):251-4. PubMed ID: 12186515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.
    Crowther MA; Ageno W; Garcia D; Wang L; Witt DM; Clark NP; Blostein MD; Kahn SR; Vesely SK; Schulman S; Kovacs MJ; Rodger MA; Wells P; Anderson D; Ginsberg J; Selby R; Siragusa S; Silingardi M; Dowd MB; Kearon C
    Ann Intern Med; 2009 Mar; 150(5):293-300. PubMed ID: 19258557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Warfarin resistance and enteral feedings.
    Martin JE; Lutomski DM
    JPEN J Parenter Enteral Nutr; 1989; 13(2):206-8. PubMed ID: 2496251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High intra- and inter-individual variability of plasma vitamin K concentrations in patients with atrial fibrillation under warfarin therapy.
    Kim YE; Woo HI; On YK; Kim JS; Lee SY
    Eur J Clin Nutr; 2015 Jun; 69(6):703-6. PubMed ID: 25828628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Warfarin metabolites: the anticoagulant activity and pharmacology of warfarin alcohols.
    Lewis RJ; Trager WF; Robinson AJ; Chan KK
    J Lab Clin Med; 1973 Jun; 81(6):925-31. PubMed ID: 4710371
    [No Abstract]   [Full Text] [Related]  

  • 60. Bridging low-molecular-weight heparin for temporary interruption of warfarin.
    Shojania AM
    Ann Intern Med; 2007 Nov; 147(9):671; author reply 671. PubMed ID: 17975192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.